Marginal increase of sunitinib exposure by grapefruit juice

A Population Pharmacokinetic Meta-analysis of Sunitinib Malate (SU11248) and Its Primary Metabolite (SU12662) in Healthy Volunteers and Oncology Patients

(2009) B. E. Houk et al.   CLINICAL CANCER RESEARCH

Effect of Grapefruit Juice on the Pharmacokinetics of Nilotinib in Healthy Participants

(2009) Ophelia Q. P. Yin et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Influence of Solute Carriers on the Pharmacokinetics of CYP3A4 Probes

(2008) RM Franke et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Sunitinib (Sutent, SU11248), a Small-Molecule Receptor Tyrosine Kinase Inhibitor, Blocks Function of the ATP-Binding Cassette (ABC) Transporters P-Glycoprotein (ABCB1) and ABCG2

(2008) S. Shukla et al.   DRUG METABOLISM AND DISPOSITION

No clinically relevant CYP3A induction after St. John’s wort with low hyperforin content in healthy volunteers

(2008) Silke C. Mueller et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Quantification of sunitinib in human plasma by high-performance liquid chromatography–tandem mass spectrometry☆

(2008) P MINKIN et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES